These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30505992)

  • 1. Macular pigment density changes in central serous chorioretinopathy.
    Tudosescu R; Alexandrescu CM; Istrate SL; Vrapciu A; Ciuluvica RC; Voinea LM
    Rom J Ophthalmol; 2018; 62(3):222-227. PubMed ID: 30505992
    [No Abstract]   [Full Text] [Related]  

  • 2. Central serous chorioretinopathy produces macular pigment profile changes.
    Putnam CM; Kinerk WT; Bassi CJ
    Optom Vis Sci; 2013 Jul; 90(7):e206-12. PubMed ID: 23770658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlations between internal and external ocular factors and macular pigment optical density.
    Tudosescu R; Alexandrescu CM; Istrate SL; Vrapciu AD; Ciuluvică RC; Voinea L
    Rom J Ophthalmol; 2018; 62(1):42-47. PubMed ID: 29796433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macular pigment optical density in central serous chorioretinopathy.
    Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Hamasaki T
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5219-25. PubMed ID: 20445108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 1-year lutein supplementation on macular pigment optical density and visual function.
    Sasamoto Y; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Graefes Arch Clin Exp Ophthalmol; 2011 Dec; 249(12):1847-54. PubMed ID: 21850440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a lutein supplement on the plasma lutein concentration and macular pigment in patients with central serous chorioretinopathy.
    Sawa M; Gomi F; Hara C; Nishida K
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5238-44. PubMed ID: 25074771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
    Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
    Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
    Stringham JM; Stringham NT
    Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Serum and Macular Carotenoids in Central Serous Chorioretinopathy.
    Ji Y; Gan Y; Su Y; Zhang Y; Li M; Mi L; Zuo C; Wen F
    Front Med (Lausanne); 2022; 9():805305. PubMed ID: 35433755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).
    Tsika C; Tsilimbaris MK; Makridaki M; Kontadakis G; Plainis S; Moschandreas J
    Acta Ophthalmol; 2011 Nov; 89(7):e573-8. PubMed ID: 21672183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macular Pigment Reflectometry: Developing Clinical Protocols, Comparison with Heterochromatic Flicker Photometry and Individual Carotenoid Levels.
    Davey PG; Rosen RB; Gierhart DL
    Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathophysiology of macular diseases--morphology and function].
    Iida T
    Nippon Ganka Gakkai Zasshi; 2011 Mar; 115(3):238-74; discussion 275. PubMed ID: 21476310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular pigment optical density in central serous chorioretinopathy.
    Polat Gultekin B; Sahli E
    Ther Adv Ophthalmol; 2021; 13():2515841421997195. PubMed ID: 33738428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
    Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
    J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
    Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of heterochromatic flicker photometry to determine macular pigment optical density in a healthy Australian population.
    Abell RG; Hewitt AW; Andric M; Allen PL; Verma N
    Graefes Arch Clin Exp Ophthalmol; 2014 Mar; 252(3):417-21. PubMed ID: 24390399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.
    Aleman TS; Cideciyan AV; Windsor EA; Schwartz SB; Swider M; Chico JD; Sumaroka A; Pantelyat AY; Duncan KG; Gardner LM; Emmons JM; Steinberg JD; Stone EM; Jacobson SG
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1319-29. PubMed ID: 17325179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macular pigment optical density spatial distribution measured in a subject with oculocutaneous albinism.
    Putnam CM; Bland PJ
    J Optom; 2014; 7(4):241-5. PubMed ID: 25323647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of features on SD-OCT between acute central serous chorioretinopathy and exudative age-related macular degeneration.
    Ahn SJ; Kim TW; Huh JW; Yu HG; Chung H
    Ophthalmic Surg Lasers Imaging; 2012; 43(5):374-82. PubMed ID: 22767337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.